Detalhe da pesquisa
1.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
Lancet Oncol
; 19(4): 474-485, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29482983
2.
Fulminant liver failure in a patient affected by polycystic liver disease and liver metastases from breast carcinoma.
Tumori
; 95(4): 557-61, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19856678
3.
Successful outcome after combined chemotherapeutic and surgical management in a case of esophageal cancer with breast and brain relapse.
World J Gastroenterol
; 12(34): 5565-8, 2006 Sep 14.
Artigo
Inglês
| MEDLINE | ID: mdl-17007002
4.
Small cell lung cancer in a young patient with osteopetrosis.
Tumori
; 92(6): 563-6, 2006.
Artigo
Inglês
| MEDLINE | ID: mdl-17260504
5.
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design.
J Clin Oncol
; 20(20): 4150-9, 2002 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12377958
6.
Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.
Eur J Cancer
; 41(2): 249-55, 2005 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-15661550
7.
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).
Sci Rep
; 5: 16331, 2015 Nov 17.
Artigo
Inglês
| MEDLINE | ID: mdl-26573509
8.
Primary small cell bladder carcinoma.
Tumori
; 93(3): 327, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17679477
9.
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.
Breast Cancer Res Treat
; 98(3): 241-8, 2006 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-16670941